SNHG26 Promotes Colorectal Cancer Progression via CDKN2A ‐Dependent Regulation of Cuproptosis and CD8 + T Cell‐Mediated Immunity

View Full Paper

Ask AI

Bookmark

SNHG26 promotes apoptosis resistance and colorectal cancer progression through the SNHG26‐CDKN2A axis.
Key evidence shows that SNHG26 overexpression correlates with increased apoptosis resistance and immune evasion.
Analysis of gain-of-function and loss-of-function approaches validated SNHG26's role in colorectal cancer progression.
Findings suggest targeting the tumour immune microenvironment may enhance therapeutic strategies against colorectal cancer.

Discussion

No takes yet. Share an insight, caveat, or question.

Observational analysis reveals gain-of-function effects on apoptosis in colorectal cancer, highlighting SNHG26's role in immune evasion.

Wan et al. (2025) studied this question.

View Full Paper

Ask AI

Bookmark